Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域：
Inflammation/Immunology
Target：
IC50: 25 μM (COX-2,in human monocytes);47 μM (COX-1,in human monocytes);
描述：
Piroxicam (CP-16171) is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC50s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively.
m.cnreagent.com
